Terms: = Thyroid cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Prognosis
41 results:
1. Clinical significance and immune landscape of angiogenesis-related genes in bladder cancer.
Liu G; Zhang T; Gui D; Liu Q
Aging (Albany NY); 2023 Nov; 15(22):13118-13133. PubMed ID: 37988196
[TBL] [Abstract] [Full Text] [Related]
2. A novel pyroptosis-related signature predicts prognosis and indicates immunotherapy in oral squamous cell carcinoma.
Gao Y; Zhang X; Li Y; Gao J; Liu S; Cai H; Zhang J
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12057-12070. PubMed ID: 37421458
[TBL] [Abstract] [Full Text] [Related]
3. A novel immune score model predicting the prognosis and immunotherapy response of breast cancer.
Lv W; He X; Wang Y; Zhao C; Dong M; Wu Y; Zhang Q
Sci Rep; 2023 Apr; 13(1):6403. PubMed ID: 37076508
[TBL] [Abstract] [Full Text] [Related]
4. Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.
Li J; Hou H; Sun J; Ding Z; Xu Y; Li G
Funct Integr Genomics; 2023 Mar; 23(2):105. PubMed ID: 36977915
[TBL] [Abstract] [Full Text] [Related]
5. Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer.
Su Y; Xu B; Li J; Shen Q; Lei Z; Ma M; Zhang F; Hu T
Ann Med; 2023 Dec; 55(1):1298-1316. PubMed ID: 36974635
[TBL] [Abstract] [Full Text] [Related]
6. The specific phagocytosis regulators could predict recurrence and therapeutic effect in thyroid cancer: A study based on bioinformatics analysis.
Hou C; Wu M; Zhang H; Yang Z
Medicine (Baltimore); 2023 Mar; 102(11):e33290. PubMed ID: 36930113
[TBL] [Abstract] [Full Text] [Related]
7. thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation.
Zhou W; Lin J; Liu J; Zhang R; Fan A; Xie Q; Hong L; Fan D
Aging (Albany NY); 2023 Feb; 15(3):846-865. PubMed ID: 36791151
[TBL] [Abstract] [Full Text] [Related]
8. Development of an Independent Prognostic Signature Based on Three Hypoxia-Related Genes for Breast cancer.
Wang H; Guo Y; Zhang P; Lin Z; Yang D; Chen J; Li Z; Zhang C; Yang H; Yan B; Han Z; Tian C
Comput Math Methods Med; 2022; 2022():2974126. PubMed ID: 36388159
[TBL] [Abstract] [Full Text] [Related]
9. TMPRSS4 is a novel biomarker and correlated with immune infiltration in thyroid carcinoma.
Xu X; Sun T; Jing J
BMC Endocr Disord; 2022 Nov; 22(1):280. PubMed ID: 36380313
[TBL] [Abstract] [Full Text] [Related]
10. Landscape of prognosis and immunotherapy responsiveness under tumor glycosylation-related lncRNA patterns in breast cancer.
Lv W; Tan Y; Zhou X; Zhang Q; Zhang J; Wu Y
Front Immunol; 2022; 13():989928. PubMed ID: 36189319
[TBL] [Abstract] [Full Text] [Related]
11. Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer.
Pan H; Pan J; Wu J
Front Immunol; 2022; 13():934221. PubMed ID: 35967425
[TBL] [Abstract] [Full Text] [Related]
12. Evaluating the tumor immune profile based on a three-gene prognostic risk model in HER2 positive breast cancer.
Lin J; Zhao A; Fu D
Sci Rep; 2022 Jun; 12(1):9311. PubMed ID: 35665772
[TBL] [Abstract] [Full Text] [Related]
13. Identification and validation of a novel pyroptosis-related lncRNAs signature associated with prognosis and immune regulation of hepatocellular carcinoma.
Zhang Z; Xia F; Xu Z; Peng J; Kang F; Li J; Zhang W; Hong Q
Sci Rep; 2022 May; 12(1):8886. PubMed ID: 35614201
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive Analysis of Prognostic and immune infiltrates for FOXPs Transcription Factors in Human Breast cancer.
Yi J; Tan S; Zeng Y; Zou L; Zeng J; Zhang C; Liu L; Fan P
Sci Rep; 2022 May; 12(1):8896. PubMed ID: 35614183
[TBL] [Abstract] [Full Text] [Related]
15. Immune Checkpoint Protein Expression Defines the prognosis of Advanced thyroid Carcinoma.
Luo Y; Yang YC; Shen CK; Ma B; Xu WB; Wang QF; Zhang Y; Liao T; Wei WJ; Wang Y
Front Endocrinol (Lausanne); 2022; 13():859013. PubMed ID: 35574031
[TBL] [Abstract] [Full Text] [Related]
16. Risk of malignancy in patients with inflammatory bowel disease: A population-based cohort study from China.
Zhang H; Zhang M; Chen X; Guo M; Zhou R; Lv H; Li Y; Tan B; Li J; Xu H; Zheng W; Yang H; Qian J
Int J Cancer; 2022 Jun; 150(11):1770-1778. PubMed ID: 35037241
[TBL] [Abstract] [Full Text] [Related]
17. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict prognosis in Triple-Negative Breast cancer.
Qiu P; Guo Q; Yao Q; Chen J; Lin J
Front Immunol; 2021; 12():736030. PubMed ID: 34659224
[TBL] [Abstract] [Full Text] [Related]
18. Cardiac Amyloidosis Presenting with Pre-Excitation Syndrome, Heart Failure, and Severe Factor X Deficiency as Part of Systemic Amyloid Light-Chain (AL) Amyloidosis - A Fatal Combination.
Almasri H; Almeer A; Awouda S; Hamid O; Sardar S; Anwer Z; Ibrahim F; Soliman D; Kandathil Y; Abu-Tineh M; Alabdul Razzak I; Alazawi SH
Am J Case Rep; 2021 Aug; 22():e933398. PubMed ID: 34413281
[TBL] [Abstract] [Full Text] [Related]
19. Permanent diabetes insipidus in a patient with mesothelioma treated with immunotherapy.
Brilli L; Calabrò L; Campanile M; Pilli T; Agostinis C; Cerase A; Maio M; Castagna MG
Arch Endocrinol Metab; 2020 Aug; 64(4):483-486. PubMed ID: 32267349
[TBL] [Abstract] [Full Text] [Related]
20. Renal Toxicity of cancer Immunother apy.
Büchler T
Klin Onkol; 2020; 33(1):29-31. PubMed ID: 32075386
[TBL] [Abstract] [Full Text] [Related]
[Next]
